Key statistics
On Friday, IMCD NV (INX:FRA) closed at 142.15, -13.90% below its 52-week high of 165.10, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 142.15 |
---|---|
High | 142.15 |
Low | 142.15 |
Bid | 151.40 |
Offer | 154.45 |
Previous close | 141.75 |
Average volume | 7.60 |
---|---|
Shares outstanding | 56.99m |
Free float | 55.99m |
P/E (TTM) | 31.00 |
Market cap | 8.71bn EUR |
EPS (TTM) | 4.93 EUR |
Annual div (ADY) | 2.24 EUR |
---|---|
Annual div yield (ADY) | 1.58% |
Div ex-date | May 16 2024 |
Div pay-date | May 21 2024 |
Data delayed at least 15 minutes, as of Nov 08 2024 07:06 GMT.
More ▼
Announcements
- IMCD reports EBITA of EUR 403 million in the first nine months of 2024
- IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America
- IMCD successfully issues a EUR 500 million rated bond
- IMCD reports EBITA of EUR 270 million in the first half of 2024
- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
More ▼